{
  "id": 10670957,
  "title": "Teva Pharmaceutical: 3 Numbers That Explain This Generic-Drug Turnaround",
  "url": "https://urgent.news/2026/09/29/teva-pharmaceutical-3-numbers-that-explain-this-generic-drug-10670957",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-29T09:55:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/teva-pharmaceutical-3-numbers-explain-generic-drug-turnaround"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsForecasts call for Teva's branded drug portfolio to bring it $3.7 billion in revenue next year.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Teva Pharmaceutical: 3 Numbers That Explain This Generic-Drug Turnaround",
        "url": "https://urgent.news/2026/09/29/teva-pharmaceutical-3-numbers-that-explain-this-generic-drug",
        "published": "2026-09-29T09:35:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}